Company profile
CRESCENT BIOPHARMA, INC.
NASDAQ:CBIOBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07335497 | phase1_2 | recruiting | 2026-02-17 | 2029-02-01 | Crescent Biopharma, Inc. | CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors |
FDA applications (0)
No records yet.